Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata

The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata

FromThe AI in Business Podcast


The Future of Pharma Data, AI, and Drug Development - with Glen de Vries of Medidata

FromThe AI in Business Podcast

ratings:
Length:
25 minutes
Released:
Jul 14, 2020
Format:
Podcast episode

Description

Glen de Vries cofounded Medidata in 1999, offering SaaS-based clinical development solutions addressing the functioning of customers' clinical trials, and 20 years later the company - which he still leads - sold to Dassault Systemes for almost $6 billion. What a triumph, Glen! Thank you for joining the podcast. Listen in as Glen shares his unique and valuable perspective on the current state and potential futures for the data ecosystem in Life Sciences. Want to stay on the cutting edge of emerging data-driven technologies? Try out Emerj Plus: emerj.com/p1
Released:
Jul 14, 2020
Format:
Podcast episode

Titles in the series (100)

Learn what's possible - and what's working - with artificial intelligence in the enterprise. Each week, Emerj founder Daniel Faggella interviews top AI and machine learning-focused executives and researchers in sectors like Pharma, Banking, Retail, Defense, and more. Discover trends, learn about what's working now, and learn how to adapt and thrive in an era of AI disruption. Be sure to subscribe to "AI in Industry."